News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
707,241 Results
Type
Article (41480)
Company Profile (262)
Press Release (665499)
Section
Business (206971)
Career Advice (2047)
Deals (35657)
Drug Delivery (97)
Drug Development (81984)
Employer Resources (175)
FDA (16282)
Job Trends (15064)
News (349454)
Policy (32961)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (5)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (6)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2653)
Accelerated approval (4)
Adcomms (21)
Allergies (80)
Alliances (50266)
ALS (84)
Alzheimer's disease (1386)
Antibody-drug conjugate (ADC) (110)
Approvals (16282)
Artificial intelligence (242)
Autoimmune disease (16)
Automation (14)
Bankruptcy (363)
Best Places to Work (11751)
BIOSECURE Act (19)
Biosimilars (103)
Biotechnology (183)
Bladder cancer (59)
Brain cancer (25)
Breast cancer (251)
Cancer (2035)
Cardiovascular disease (166)
Career advice (1712)
Career pathing (30)
CAR-T (143)
Cell therapy (406)
Cervical cancer (19)
Clinical research (66383)
Collaboration (779)
Compensation (463)
Complete response letters (20)
COVID-19 (2651)
CRISPR (37)
C-suite (218)
Cystic fibrosis (100)
Data (1992)
Decentralized trials (2)
Denatured (16)
Depression (40)
Diabetes (252)
Diagnostics (6438)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (116)
Drug pricing (96)
Drug shortages (25)
Duchenne muscular dystrophy (85)
Earnings (86547)
Editorial (33)
Employer branding (22)
Employer resources (149)
Events (113565)
Executive appointments (658)
FDA (17410)
Featured Employer (51)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (707)
Gene editing (98)
Generative AI (21)
Gene therapy (286)
GLP-1 (705)
Government (4452)
Grass and pollen (4)
Guidances (49)
Healthcare (19083)
Huntington's disease (22)
IgA nephropathy (24)
Immunology and inflammation (104)
Indications (26)
Infectious disease (2786)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (48)
Intellectual property (87)
Interviews (315)
IPO (16553)
IRA (40)
Job creations (3744)
Job search strategy (1459)
Kidney cancer (10)
Labor market (34)
Layoffs (465)
Leadership (16)
Legal (8044)
Liver cancer (72)
Lung cancer (295)
Lymphoma (135)
Machine learning (4)
Management (58)
Manufacturing (271)
MASH (62)
Medical device (13456)
Medtech (13461)
Mergers & acquisitions (19584)
Metabolic disorders (641)
Multiple sclerosis (73)
NASH (17)
Neurodegenerative disease (84)
Neuropsychiatric disorders (24)
Neuroscience (1878)
NextGen: Class of 2025 (6605)
Non-profit (4616)
Northern California (2453)
Now hiring (37)
Obesity (345)
Opinion (203)
Ovarian cancer (72)
Pain (79)
Pancreatic cancer (77)
Parkinson's disease (138)
Partnered (20)
Patents (204)
Patient recruitment (98)
Peanut (46)
People (58466)
Pharmaceutical (67)
Pharmacy benefit managers (18)
Phase I (20694)
Phase II (29217)
Phase III (21768)
Pipeline (1057)
Podcasts (47)
Policy (116)
Postmarket research (2606)
Preclinical (8836)
Press Release (67)
Prostate cancer (94)
Psychedelics (32)
Radiopharmaceuticals (247)
Rare diseases (367)
Real estate (6021)
Recruiting (67)
Regulatory (22418)
Reports (46)
Research institute (2422)
Resumes & cover letters (353)
Rett syndrome (4)
RNA editing (4)
RSV (40)
Schizophrenia (64)
Series A (125)
Series B (80)
Service/supplier (11)
Sickle cell disease (53)
Southern California (2125)
Special edition (14)
Spinal muscular atrophy (150)
Sponsored (29)
Startups (3670)
State (2)
Stomach cancer (13)
Supply chain (61)
Tariffs (11)
The Weekly (29)
United States (21485)
Vaccines (670)
Venture capitalists (37)
Webinars (12)
Weight loss (228)
Women's health (33)
Worklife (15)
Date
Today (88)
Last 7 days (715)
Last 30 days (2749)
Last 365 days (33897)
2025 (8285)
2024 (35666)
2023 (40538)
2022 (51705)
2021 (56282)
2020 (54644)
2019 (47235)
2018 (35590)
2017 (32720)
2016 (32197)
2015 (38237)
2014 (31924)
2013 (26988)
2012 (29111)
2011 (29775)
2010 (27852)
Location
Africa (744)
Alabama (50)
Alaska (7)
Arizona (224)
Arkansas (13)
Asia (38431)
Australia (6317)
California (5589)
Canada (1889)
China (477)
Colorado (248)
Connecticut (262)
Delaware (128)
Europe (83689)
Florida (826)
Georgia (196)
Idaho (57)
Illinois (507)
India (24)
Indiana (292)
Iowa (9)
Japan (143)
Kansas (101)
Kentucky (23)
Louisiana (8)
Maine (69)
Maryland (840)
Massachusetts (4257)
Michigan (211)
Minnesota (377)
Mississippi (2)
Missouri (78)
Montana (28)
Nebraska (25)
Nevada (56)
New Hampshire (63)
New Jersey (1594)
New Mexico (30)
New York (1612)
North Carolina (947)
North Dakota (8)
Northern California (2453)
Ohio (193)
Oklahoma (14)
Oregon (36)
Pennsylvania (1266)
Puerto Rico (10)
Rhode Island (27)
South America (1125)
South Carolina (18)
South Dakota (1)
Southern California (2125)
Tennessee (95)
Texas (837)
Utah (166)
Virginia (133)
Washington D.C. (57)
Washington State (519)
West Virginia (3)
Wisconsin (50)
707,241 Results for "frontier scientific inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Avirmax Inc. to Present at the ARVO Frontiers in Ocular Gene Therapy Research Conference
November 12, 2024
·
2 min read
Press Releases
Frontier Medicines to Participate in Two Upcoming March Investor Conferences
February 27, 2025
·
1 min read
Press Releases
IPA and RIBOPRO Partner to Advance mRNA-Driven Antibody Discovery, Unlocking New Frontiers in Immunotherapy
February 26, 2025
·
5 min read
Press Releases
Topas Therapeutics Publishes Foundational Data Demonstrating Tolerance Induction by its Proprietary Nanoparticle Platform in Frontiers in Immunology
March 17, 2025
·
3 min read
Press Releases
Brenus Pharma Publishes Promising Proof of Concept Results of their Therapeutic Platform in the Scientific Frontiers in Oncology Journal. (1)
November 7, 2024
·
2 min read
Press Releases
AMWC 2025: Galderma Pushes the Innovation Frontier With Updates From Its Unparalleled Portfolio Designed to Meet the Needs of the Aesthetic Community
March 20, 2025
·
16 min read
Press Releases
Immunic, Inc. to Participate in Scientific and Industry Conferences in April
April 1, 2025
·
5 min read
Press Releases
Phio Pharmaceuticals Announces Publication in Frontiers in Immunology
Journal is the official publication of the International Union of Immunological Societies
December 12, 2024
·
4 min read
Lone Star Bio
Coya Therapeutics Announces Publication of ALS Study in Peer-Reviewed Journal Frontiers in Neurology
Coya Therapeutics, Inc. announces the publication of a peer-reviewed manuscript titled, “A Phase 1 Proof-of-Concept Study Evaluating Safety, Tolerability, and Biological Marker Responses with Combination Therapy of CTLA4-Ig and Interleukin-2 in Amyotrophic Lateral Sclerosis,” in the medical journal Frontiers in Neurology.
June 11, 2024
·
13 min read
Press Releases
Quince Therapeutics Announces Frontiers in Neurology Publication of Long-Term Safety of EryDex in Pediatric Patients with Ataxia-Telangiectasia
January 27, 2025
·
8 min read
1 of 70,725
Next
